… The purpose of this study was to evaluate the effectiveness of outpatient remdesivir in
comparison with sotrovimab and a matched high-risk control group in preventing COVID-19-…

… In conclusion, this study represents one of the first efforts at real-life data collection on
COVID-19 outpatient treatment options. We observed a low incidence of adverse events and …

… treatment to evaluate effectiveness and the populations most … Sixth, treatment with other
outpatient therapies for COVID-19 … In conclusion, in this large study of outpatients with COVID-19…

… the real-world effectiveness of these therapies for COVID-19 in SOTR during the Omicron
era is largely uncharacterized. To address this knowledge gap, we conducted a retrospective …

… evidence that presents novel results on both a high effectiveness of mAb treatment in …
surging cases of COVID-19; however, prior studies could not evaluate effectiveness of mAbs …

… To our knowledge, the current study is one of the first to examine the effectiveness of
nirmatrelvir–ritonavir in non-hospitalised patients during the omicron period of the …

… real-world evidence for effectiveness of sotrovimab treatment in reducing hospitalizations
among COVID-19 outpatients … For hospitalized patients, prior outpatient sotrovimab treatment …

… Different antivirals are available for the treatment of outpatients with COVID-19. Our aim was
to describe a real-world experience of outpatient management of COVID-19 subjects at high …

… -related hospitalization among patients diagnosed with COVID-19 in the outpatient
setting who were treated with casirivimab and imdevimab compared with untreated EUA-eligible …

… This observational cohort study confirms and extends the evidence from clinical trials and
other smaller real-world studies that patients with COVID-19 in the outpatient setting benefit …